Benitec Corp (BNTC) - Biznesning o‘zini qoplash muddati

Benitec Corp (BNTC) korporativ emblemasi va logotipi

FDA ning eksklyuziv huquqlari va mustahkam patent himoyasi ushbu tor doiradagi soha uchun yangi ishtirokchilarning kirishiga jiddiy to'siqlarni yaratadi. Benitec Biopharma Inc. (BNTC) og'ir irsiy patologiyalar uchun bir martalik davolash usullarini ishlab chiqishda o'zining innovatsion ddRNAi platformasidan foydalanadi. Biroq, daromadlilikning yetishmasligi va kapitalga bog'liqlik uning moliyaviy holatini beqaror qiladi. Bozor kapitalizatsiyasi tendentsiyasi -7.00 darajasida qotgan bo'lib, bu klinik sinovlarning joriy bosqichini ifodalaydi.

BNTC: Benitec P/E multiplikatori 04.07.2022 - 12.11.2026

Benitec (BNTC) kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Aksiya kursi benitec.com|BNTC - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor kapitallashuvi Benitec Biopharma Inc.|BNTC - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning balans narxi Benitec Biopharma|BNTC - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga koeffitsiyenti benitec.com|BNTC - Kompaniyaning umumiy aktivlari
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning xususiy kapitalga nisbati Benitec Biopharma Inc.|BNTC - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Benitec Corp|BNTC - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati Benitec Biopharma Inc.|BNTC - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Benitec Biopharma|Shoshilinch likvidlik benitec.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
BNTC - Kompaniyaning sof foydasi|Forvard foyda Benitec Biopharma Inc.|BNTC - P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori Benitec Biopharma Inc|BNTC - PEG multiplikatori|EV/EBITDA multiplikatori Benitec Biopharma Inc.|BNTC - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Benitec Biopharma|BNTC - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi benitec.com|BNTC - Joriy yilda foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Benitec Biopharma Inc.
Kompaniyaning jamlanma tahlili:benitec.com
Benitec Corp brend mahsuloti

Benitec Biopharma Inc. (BNTC) noyob genetik patologiyalarni davolash uchun innovatsion ddRNAi dori vositalarini ishlab chiqishga e'tibor qaratadi. Benitec Biopharma Inc. (BNTC) ning P/E grafigini tahlil qilib, investor joriy bozor kapitalizatsiyasining har bir aksiya uchun sof foyda miqdoriga nisbatini ko'radi. Ushbu koeffitsient foydaning har bir dollari qiymatini belgilab, aktivning haddan tashqari qimmat yoki arzon baholanganligini aniqlash imkonini beradi. Biofarmatsevtika startapi uchun bunday metrika klinik sinovlarning kelgusidagi muvaffaqiyatiga bo'lgan bozor kutganliklarining ko'rsatkichi bo'lib xizmat qiladi.

Muhim raqobatchilar

Narx-foyda multiplikatori TEM (Tempus AI Inc)|P/E multiplikatori QGEN|Biznesning o‘zini qoplash muddati Ionis Pharmaceuticals, Inc.|Repligen Corp. - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati RNA (Avidity Corp)|CRISPR Therapeutics AG - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati genedx.com|RARE: P/E multiplikatori|Narx-foyda koeffitsiyenti Beam Therapeutics Inc|Narx-foyda koeffitsiyenti SRPT|TWST: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori TXG|Narxning foydaga nisbati NTLA (intelliatx.com)|P/E multiplikatori STOK (Stoke Therapeutics, Inc.)|Biznesning o‘zini qoplash muddati BioLife Solutions Inc (BLFS)|WVE - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Maze Therapeutics Corp|Sionna Therapeutics Inc (SION) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati PRME (primemedicine.com)|TSHA (Taysha Gene Therapies, Inc.) - P/E multiplikatori|QURE: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori MGTX|P/E multiplikatori REGENXBIO Corp (RGNX)|Narxning foydaga nisbati Solid Biosciences Inc. SLDB|Kompaniya qiymatining sof foydaga nisbati OCGN|PACB - Narxning foydaga nisbati|Design Therapeutics Inc (DSGN) - Narx-foyda koeffitsiyenti|RCKT: P/E multiplikatori|4D Molecular Corp (FDMT) - P/E multiplikatori|Narx-foyda koeffitsiyenti LXEO|KRRO: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori EDIT|Biznesning o‘zini qoplash muddati Silence Therapeutics PLC|Narxning foydaga nisbati ProQR Therapeutics PRQR|CDXS: Narx-foyda multiplikatori|Sangamo Therapeutics - P/E multiplikatori|Nautilus Biotechnology (NAUT) - Narx-foyda koeffitsiyenti|MGX (Metagenomi) - Narx-foyda koeffitsiyenti|DTIL - Biznesning o‘zini qoplash muddati|GBIO (Generation Bio Co) - P/E multiplikatori|Narxning foydaga nisbati BOLD|Narxning foydaga nisbati Exicure, Inc. (XCUR)|imunon.com - Narx-foyda multiplikatori|Phio Pharmaceuticals Corp. - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati MBIO (Mustang Bio Inc)|TransCode - P/E multiplikatori|Bionano Genomics, Inc. (BNGO) - Narx-foyda koeffitsiyenti|APDN: P/E multiplikatori|Narx-foyda multiplikatori BLUE|Narxning foydaga nisbati ImmunoPrecise Antibodies Ltd|Narx-foyda multiplikatori OMGA (Omega Therapeutics Inc)|P/E multiplikatori OMIC|P/E multiplikatori Regulus (RGLS)|P/E multiplikatori SYRS (Syros Pharmaceuticals)|telesisbio.com - Narxning foydaga nisbati|TRACON Pharmaceuticals, Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Unity Biotechnology Inc.